Clinical Trial Update: Clinical Study of 18F-LNC1007 Injection PET/CT [Phase 1]

View source ↗

Summary

Phase 1 clinical study update for the PET radiotracer 18F-LNC1007 Injection, conducted in healthy volunteers and cancer patients; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• 18F-LNC1007 Injection

Snippet

Sponsor: Yantai LNC Biotechnology Singapore PTE. LTD. | Conditions: Healthy Volunteers, Cancer Patients | Phase 1 | Status: COMPLETED